Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2271-2281

  Cohen, Gerald ^a   Raupachova, Jana ^a   Ilic, Dalibor ^b   Werzowa, Johannes ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HELIOS Klinikum Aue   (Germany)

Author keywords

haemodialysis; leptin; polymorphonuclear leucocyte functions; signal transduction

Indexed keywords

LEPTIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; HEMODIALYSIS PATIENT; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FAILURE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHEMOTAXIS; FEMALE; GLUCOSE; HUMANS; I-KAPPA B KINASE; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; NEUTROPHILS; PHAGOCYTOSIS; PHOSPHORYLATION; PROGNOSIS; RENAL DIALYSIS; RESPIRATORY BURST; RISK FACTORS; TETRADECANOYLPHORBOL ACETATE;

EID: 79959921786     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq731     Document Type: Article

References (53)

1. Hauser AB, Stinghen AE, Kato S et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int 2008; 28 (Suppl 3): S183-S187.
2. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006; 19: 291-296. (Pubitemid 44091703)
3. Mahajan S, Kalra OP, Asit KT et al. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren Fail 2005; 27: 357-360. (Pubitemid 40993681)
4. Sardenberg C, Suassuna P, Andreoli MC et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006; 21: 160-165. (Pubitemid 43057125)
5. Anding K, Gross P, Rost JM et al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073. (Pubitemid 37220313)
6. Jin H, Xu Q, Zhou P et al. Impaired gp-91phox gene expression and dysfunction of peripheral blood neutrophils in patients maintaining hemodialysis. Chin Med J (Engl) 2000; 113: 120-123.
7. Shimazu T,Ominato M, Toyama Ket al. Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int Suppl 2001; 78: S137-S143. (Pubitemid 32144086)
8. Ritchey EE, Wallin JD, Shah SV. Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 1981; 19: 349-358. (Pubitemid 11145617)
9. Cohen G, Hörl WH. Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest 2004; 34: 774-781. (Pubitemid 39524303)
10. Cohen G, Rudnicki M, Deicher R et al. Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. Eur J Clin Invest 2003; 33: 669-676. (Pubitemid 36918629)
11. Cohen G, Rudnicki M, Walter F et al. Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J Am Soc Nephrol 2001; 12: 1264-1271. (Pubitemid 32472641)
12. Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48-S52. (Pubitemid 32144069)
13. Diez JJ, Iglesias P, Fernandez-Reyes MJ et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005; 62: 242-249. (Pubitemid 40203922)
14. Cohen G, Ilic D, Raupachova J et al. Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol 2008; 181: 3761-3768.
15. Caldefie-Chezet F, Poulin A, Tridon A et al. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukoc Biol 2001; 69: 414-418. (Pubitemid 32221445)
16. Caldefie-Chezet F, Poulin A, Vasson MP. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res 2003; 37: 809-814. (Pubitemid 36939597)
17. Ottonello L, Gnerre P, Bertolotto M et al. Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 2004; 15: 2366-2372. (Pubitemid 39159336)
18. Montecucco F, Bianchi G, Gnerre P et al. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann N Y Acad Sci 2006; 1069: 463-471. (Pubitemid 43989890)
19. McCall AL, Gould JB, Ruderman NB. Diabetes-induced alterations of glucose metabolism in rat cerebral microvessels. Am J Physiol 1984; 247: E462-E467. (Pubitemid 15202625)
20. Ferreiro DU, Komives EA. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry 2010; 49: 1560-1567.
21. Matarese G, La Cava A. The intricate interface between immune system and metabolism. Trends Immunol 2004; 25: 193-200. (Pubitemid 38368167)
22. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943. (Pubitemid 36513344)
23. Axelsson J, Bergsten A, Qureshi AR et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596-604. (Pubitemid 43164455)
24. Aminzadeh MA, Pahl MV, Barton CH et al. Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes. Nephrol Dial Transplant 2009; 24: 3626-3631.
25. Magni P, Liuzzi A, Ruscica M et al. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) 2005; 62: 189-196. (Pubitemid 40203914)
26. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6: 438-446.
27. Lamas O, Marti A, Martinez JA. Obesity and immunocompetence. Eur J Clin Nutr 2002; 56 (Suppl 3): S42-S45.
28. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-446.
29. Bossola M, Muscaritoli M, Valenza V et al. Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 2004; 97: C76-C82. (Pubitemid 39077822)
30. Heimburger O, Lonnqvist F, Danielsson A et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-1430. (Pubitemid 27491233)
31. Sinha MK, Ohannesian JP, Heiman ML et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347. (Pubitemid 26086355)
32. Patruta SI, Edlinger R, Sunder-Plassmann G et al. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998; 9: 655-663. (Pubitemid 28186054)
33. Dahlgren C. Polymorphonuclear leukocyte chemiluminescence induced by formylmethionyl-leucyl-phenylalanine and phorbol myristate acetate: effects of catalase and superoxide dismutase. Agents Actions 1987; 21: 104-112. (Pubitemid 17118314)
34. Lewis SL, Van Epps DE. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 9: 381-395. (Pubitemid 17090636)
35. Paul JL, Roch-Arveiller M, Man NK et al. Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 1991; 57: 428-432.
36. Perianayagam MC, Balakrishnan VS, Guo D et al. Quantification of Bax and Bcl2 in polymorphonuclear leukocytes from haemodialysis patients: relation to hydrogen peroxide. Eur J Clin Invest 2003; 33: 905-911. (Pubitemid 37220054)
37. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif 1998; 16: 290-300.
38. Ding J, Vlahos CJ, Liu R et al. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J Biol Chem 1995; 270: 11684-11691.
39. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009; 297: E1247-E1259.
40. Myers MGJr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004; 59: 287-304.
41. Bjorbaek C, Uotani S, da Silva B et al. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686-32695. (Pubitemid 28011961)
42. Bruno A, Conus S, Schmid I et al. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol 2005; 174: 8090-8096. (Pubitemid 40806320)
43. Coffer PJ, Geijsen N, M'Rabet L et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J 1998; 329: 121-130. (Pubitemid 28022299)
44. Chen Q, Powell DW, Rane MJ et al. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol 2003; 170: 5302-5308. (Pubitemid 36554765)
45. Vlahos CJ, Matter WF, Brown RF et al. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J Immunol 1995; 154: 2413-2422.
46. Wrann CD, Tabriz NA, Barkhausen T et al. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. J Immunol 2007; 178: 5940-5948. (Pubitemid 46674391)
47. Popa-Nita O, Proulx S, Pare G et al. Crystal-induced neutrophil activation: XI. Implication and novel roles of classical protein kinase C. J Immunol 2009; 183: 2104-2114.
48. Querfeld C, Rizvi MA, Kuzel TM et al. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. J Invest Dermatol 2006; 126: 1641-1647.
49. Mattioli B, Giordani L, Quaranta MG et al. Leptin exerts an antiapoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Lett 2009; 583: 1102-1106.
50. Maya-Monteiro CM, Almeida PE, D'Avila H et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J Biol Chem 2008; 283: 2203-2210.
51. Lam QL, Liu S, Cao X et al. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol 2006; 36: 3118-3130. (Pubitemid 44932714)
52. Cohen G, Raupachova J,Wimmer Tet al. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2512-2519.
53. Fernandez-Riejos P, Najib S, Santos-Alvarez J et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010. doi:10.1155/ 2010/568343